Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma
BLOOD
Walewski, J; Paszkiewicz-Kozik, E; Warszewska, A; Borsaru, G; Moicean, A; Hellmann, A; Mayer, J; Hauns, B; Mais, A; Henning, SW; Hentsch, B, 2011: Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma. BLOOD 118(21), p. 1149 - 1149
CEITEC authors: